Welcome to our dedicated page for Aurora Cannabis news (Ticker: $ACB), a resource for investors and traders seeking the latest updates and insights on Aurora Cannabis stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Aurora Cannabis's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Aurora Cannabis's position in the market.
Rhea-AI Summary
Aurora Cannabis Inc. has acquired the remaining 90% equity interest of MedReleaf Australia for AUD$50 million, making it the largest global medical cannabis company operating in nationally legal markets. The transaction is expected to be immediately accretive to Adjusted EBITDA and accelerate the Company's plan for Positive Free Cash Flow generation in 2024. The Australian medical cannabis market is rapidly growing and is estimated to be worth approximately AUD$400 million, with MedReleaf Australia holding the #2 position in the market. The acquisition is a strategic milestone for Aurora, strengthening its presence in Australia and supporting its path to profitability.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.03%
Tags
-
Rhea-AI Summary
Aurora Cannabis Inc. re-affirms its expectation of positive annual Adjusted EBITDA for fiscal 2024 and positive Free Cash Flow generation in calendar 2024. The company also announces its intention to consolidate common shares and schedules its Q3 2024 investor conference call for February 8, 2024. Adjusted EBITDA is expected to be positive on an annual basis in fiscal 2024, and management continues to expect positive free cash flow in calendar 2024. The Board of Directors has approved a plan to consolidate all outstanding Common Shares on the basis of 1 Common Share for every 10 Common Shares currently outstanding.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.04%
Tags
-
News
Rhea-AI Summary
Aurora Cannabis Inc. (ACB) announces the launch of three new cannabis-infused beverages exclusively for veteran patients, available at Aurora Medical. The products, produced by Vacay and Versus, offer THC, CBD, and CBG options in three fruity flavors. The company aims to meet the needs of patients seeking alternative forms of cannabis to support their wellbeing.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.31%
Tags
Rhea-AI Summary
Aurora Cannabis Inc. (ACB) achieved record positive adjusted EBITDA of $3.4 million, with quarterly net revenue rising 30% YoY to $63.4 million. The company also has a net cash position of over $200 million and expects to repay the remaining US$5.3 million balance of Convertible Senior Notes in February 2024. The Q2 2024 results show strong growth in global medical cannabis and a positive outlook for achieving positive free cash flow in calendar year 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.62%
Tags
-
Rhea-AI Summary
Aurora Cannabis Inc. has scheduled a conference call to discuss its second quarter fiscal year 2024 results on November 9, 2023. The call will be hosted by the CEO and CFO. Aurora is a pioneer in the global cannabis market, serving both medical and consumer markets. The company's brands include Aurora Drift, San Rafael '71, Daily Special, Tasty's, Whistler, Being, and Greybeard. Aurora's common shares trade on the NASDAQ and TSX under the symbol 'ACB'.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.56%
Tags
-
Rhea-AI Summary
Aurora Cannabis announces settlement of patent litigation
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.85%
Tags
Rhea-AI Summary
Aurora Cannabis Inc. closes bought deal offering, saving almost C$2 million in annual interest payments
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.11%
Tags
-
Rhea-AI Summary
Aurora Cannabis launches new brand TASTY'S promising great product and taste. Includes 50% THC pre-rolls and 1,000mg vapes. Targets pre-roll segment growth.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.12%
Tags
-
Rhea-AI Summary
Aurora Cannabis Inc. receives approval to transfer listing to Nasdaq Capital Market and agrees to repurchase $9.6 million worth of convertible notes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.12%
Tags
Rhea-AI Summary
Aurora Cannabis repurchases $12.3 million of convertible senior notes, reducing debt and annual cash interest costs
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
Aurora Cannabis Inc.
NYSE:ACB
ACB Rankings
ACB Stock Data
402.50M
54.39M
6.96%
9.31%
Medicinal and Botanical Manufacturing
Manufacturing
United States of America
Edmonton
About ACB
aurora is a canadian company and licensed producer of artisanal medical marijuana pursuant to the marihuana for medical purposes regulations. we ensure the highest quality, reliability, and safety of our products through advanced cultivation techniques carried out in our 55,200 square foot expandable state-of-the-art production facility in alberta, canada. aurora’s wholly-owned subsidiary, australis capital inc., seeks to be an active participant in the u.s. cannabis market.